Investigators: Dr Fiona Blyth, Dr Jian Sheng Chen (CI), Prof Judy Simpson.

Osteoporosis is still under-treated in Australia although PBS-listed anti-resorptive drugs for its treatment have been available for more than 10 years. This highlights the need for identification of barriers to the treatments and assessment of the effectiveness of anti-resorptive drugs in clinical practice in the general population. This project aims to evaluate osteoporosis management in Australia. It seeks to assess the effectiveness of anti-resorptive drugs in clinical practice, to identify barriers to the treatments, and to examine adverse drug reaction incidence in a ‘real world’ setting.

The aims are:

  • To evaluate the effectiveness of anti-resorptive drug therapies for primary and secondary prevention of fractures
  • To evaluate the impact of anti-resorptive medication and mortality
  • To determine to what extent the current osteoporosis management is ensuring patients with osteoporosis are appropriately treated
  • To examine adverse drug reaction incidence in a ‘real world’ setting with various anti-resorptive therapies.